• Center on Health Equity and Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

What We're Reading: AMA Wants to Ban TV Ads for Drugs

Article

What we're reading, November 19, 2015: the American Medical Association is calling for a ban on direct-to-consumer television advertisement of prescription drugs and popular silver plans on HealthCare.gov have largest premium increases.

AMA Calls for Ban on TV Advertising of Drugs, Devices

Physicians at the Interim Meeting of the American Medical Association (AMA) supported an advertising ban based on concerns that the increase of direct-to-consumer advertising of prescription drugs is driving demand for expensive treatments despite the fact that there are clinically effective, less costly options. Currently, the US and New Zealand are the only 2 countries that allow direct-to-consumer advertising of prescription drugs.

Read more.

Most Popular ACA Plans See Large Premium Increases

The most popular plans purchased through HealthCare.gov are the silver plans, and a new analysis from The Wall Street Journal has found that premiums for these plans are rising double-digit percentages in 20 state-capital counties. Another 10 states are seeing increases that are more modest. In the majority (17) of the states with increases, consumers don’t even have the option of switching to another insurer and paying a lower premium. The best they can do is switch to a plan with a smaller increase.

Read more.

Businesses With Less Than 50 Workers Face Tough Decisions Due to ACA

As businesses with 50 or more full-time equivalent employees become required to offer workers health insurance or face penalties, small businesses on the edge are faced with the decision of whether they can afford to grow their companies, reports The New York Times. While nearly all large companies provide healthcare benefits, just more than half (54%) of businesses with 3 to 49 workers offer that coverage.

Read more.

Related Videos
Pat Van Burkleo
Screenshot of Jennifer Vaughn, MD, in a Zoom video interview
Pat Van Burkleo
Patrick Vermersch, MD, PhD
dr mitzi joi williams
dr dalia rotstein
dr marisa mcginley
James Robinson, PhD, MPH, University of California, Berkeley
Carrie Kozlowski
Carrie Kozlowski
Related Content
© 2024 MJH Life Sciences
AJMC®
All rights reserved.